← FDA Drug Approvals (Drugs@FDA)

NAPROXEN SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVELGENIX THERAPS · Approved 2018-11-16

Drug application

FDA Application #

ANDA207612

Application type

Abbreviated New Drug Application (Generic)

Brand name

NAPROXEN SODIUM

Generic name

Naproxen Sodium

Active ingredients

NAPROXEN SODIUM

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

NOVELGENIX THERAPS

First approval

2018-11-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown